Prescription Delivery Service Market

Prescription Delivery Service Market Overview for 2024 to 2034

The prescription delivery service market is evaluated to be sized at USD 165.4 million in 2024. During the period from 2024 to 2034, the market is expected to progress at a solid clip, registering a CAGR of 5.7%. By 2034, the prescription delivery service market is anticipated to have reached a value of USD 287.9 million.

Attributes	Details
Prescription Delivery Service Market Value for 2024	USD 165.4 million
Projected Market Value for 2034	USD 287.9 million
Value-based CAGR of Market for 2024 to 2034	5.7%

Global Prescription Delivery Service Market Overview

• With patients less hesitant to take the help of online means for medical services, prescription delivery services are capturing the imagination of consumers.
• Suppliers in the market have made available service plans for the routine delivery of drugs in the time gaps of the consumer’s choosing, thus continuing to foster the demand.
• Increasingly hectic lives of modern working professionals are seeing consumers waver towards means of obtaining medicine online and thus the prescription delivery service market is progressing.
• Rise in the number of doctors prescribing e-prescriptions is benefitting the market, as patients are able to get the full experience online, from diagnosis to medication.
• Flourishing of the telemedicine industry is conducive to the growth of the market, as consumers become more inclined to online means for medical services.

Trends in the Prescription Delivery Services Market

• Use of drone technology for the delivery of prescription drugs, especially in remote and conflict-stricken areas, is enhancing the reputation of the market.
• As mental health gets more spotlight, there is increasing demand for drugs for the treatment of mental disorders. Thus, prescription delivery services are being called upon for the delivery of mental health-related drugs in increasing measure.
• Stakeholders in the market are improving the authentication process through the means of digital authentication. Thus, the market is overcoming the hurdle of problems caused by false or improper authentication.
• Geriatric population getting more comfortable with technology is enabling the progress of the market as they represent a significant consumer base for prescription delivery services.
• Pharmacies in the market taking the help of delivery software like Locate2u to streamline the process of delivery and make them faster, is impacting the demand for the services positively.
• Threat of counterfeit drugs and the risk of injecting the wrong medication are factors constraining the growth of the market.
• Lack of consumer awareness regarding the availability of the service, especially in underdeveloped areas of the world, is set to restrict the growth of the market.

Category-wise Outlook

Prescription drugs retain their position at the top of the pile in the service type segment. Physical delivery remains the predominant mode of delivery.

Progressing Prescription Practices Through Online Means Raising the Demand for Prescription Drugs Through Delivery

Prescription drugs are expected to account for 25.2% of the market share in 2024. Some of the factors influencing the increase in delivery of prescription drugs are:

• Increasing number of patients resorting to online means for prescriptions is aiding the demand for delivery of prescription drugs through the same mode.
• Rise in the number of patients suffering from chronic ailments is leading to a surge in the need for prescription drugs.

Attributes	Details
Top Service Type	Prescription Drugs
Market Share (2024)	25.2%

Physical Delivery Makes its Presence Felt in the Delivery Technology Segment

Physical delivery of prescription drugs is anticipated to account for 32.5% of the market share in 2024. Some of the reasons for the progress of physical delivery are:

• Simplicity of physical delivery emboldens it to suppliers and thus the physical mode of delivery emerges at the top.
• Physical mode of delivery adds an extra layer of security to the delivery service and thus continues to be the go-to delivery solution.

Attributes	Details
Top Delivery Technology	Physical Delivery
Market Share (2024)	32.5%

Country-Wise Analysis

Robust healthcare sector in the Asia Pacific is inspiring the growth of the market in the region. Initiatives to have medications reach remote corners of the region are also propelling the market.

European consumer’s familiarity with technology makes Europe a happy hunting ground for the market. Treatments and diagnoses moving to the online field are also influencing the market’s growth in the region.

Countries	CAGR (2024 to 2034)
Spain	5.2%
India	6.5%
Italy	5.3%
France	5.3%
Germany	5.1%

Rise in Number of Non-communicable Diseases Infecting the Market with Growth in Spain

The CAGR of the market for the forecast period in Spain is anticipated to be 5.2%. Some of the factors influencing the growth of the market in the country are:

• Non-communicable diseases are responsible for the majority of deaths in Spain and to treat these diseases, prescription delivery services are being sought increasingly.
• Spanish consumers are taking advantage of plans provided for timely delivery of drugs and thus the market is developing positively in the country.

Stakeholders Utilizing Marketing to Expand Scope of the Market in India

The market is expected to register a CAGR of 6.5% in India through 2034. Some of the factors responsible for the growth of the market are:

• Market players in India are taking the route of celebrity endorsement to increase the demand for the service in the country, for example, Netmeds tapping film stars for advertising.
• Chronically online Indian population is reverting to an increasing number of services through online means and this tendency is benefitting the market’s prospects in India.

French Companies Partnering with Foreign Entities to Expand Market Scope

The market is expected to progress at a CAGR of 5.3% in France for the forecast period. Some factors influencing the progress are:

• French companies are establishing collaborations with foreign players to get access to the latest technologies and medicines to increase the scope of prescription delivery service.
• Working professionals in France are loathe to take precious time out of the day and stand in line for prescriptions and thus prescription delivery service is being preferred in the country.

Italy Among the Beneficiaries of the Drone Delivery Service of Medication

The market is expected to progress at a CAGR of 5.3% in Italy throughout the forecast period. Some factors influencing the progress are:

• Italy is penned in to be one of the first countries to benefit from Amazon’s drone delivery for medicines program and thus the demand for prescription delivery service is set to benefit in the country.
• Italy’s population is aging rapidly, with the Organisation for Economic Co-operation and Development (OECD), putting their aging rate to be highest of any non-Asian country. Thus, the need for prescription delivery service is rising in the country.

Timeliness of Delivery Valued in Germany

The market is expected to progress at a CAGR of 5.1% in Germany. Some factors influencing the progress are:

• German consumers value fast delivery of medicines and thus market players are focused on speeding up the delivery process. For example, MAYD strives to deliver medication within 30 minutes across Germany.
• Germany’s fast-developing e-pharmacy market is complementing the growth of the prescription delivery service industry in the country.

Competitive Landscape in the Prescription Delivery Service Market

Notable players in the market are engaged in acquisitions and mergers to enhance their footprint in the market. Advancements with the help of technology are at the forefront of strategy.

Walmart is bringing its celebrated delivery service model to its prescription delivery service. Other market players are focusing on partnering with delivery platforms to increase their capabilities and compete with the top companies.

Recent Developments in the Prescription Delivery Service Market

• In 2023, Michigan Medicine and Zipline partnered to make drone delivery of drugs available, with the help of an electric drone, for residents in Washtenaw County, United States.
• Also in 2023, Amazon started delivering drugs through the mode of drones, with College Station, United States the first beneficiary of its service.
• In 2021, Uber partnered with ScriptDrop to help prescription drug delivery become faster. The company is planning to leverage this partnership for same-day drug delivery.

Key Companies in the Prescription Delivery Service Market

• Wal-Mart Stores, Inc
• Walgreen Co.
• CVS Health
• Express Scripts Holding Company
• Giant Eagle, Inc.
• DocMorris (Zur Rose Group AG)
• Rowlands Pharmacy
• OptumRx, Inc.
• Ali Health
• Kroger Co.
• Amazon (PillPack)

Key Coverage in the Prescription Delivery Service Market Report

• Prescription Delivery Service Market Demand Analysis
• Prescription Delivery Services Market Growth Assessment
• Global Prescription Delivery Service Market Size and Share Report
• Sales Analysis Of Prescription Delivery Services
• Coverage of Opportunities For Prescription Delivery Services Manufacturers
• Prescription Delivery Service Market Share in Overall Medication delivery industry

Table of Content

• 1. Executive Summary
• 2. Market Overview
• 3. Market Background
• 4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034
• 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Disease Indication
  • 5.1. Diabetes
  • 5.2. Hypertension
  • 5.3. Cholesterols Disorders
  • 5.4. Wellness Supplement
  • 5.5. Diagnostics Kits
  • 5.6. OTC Drugs
• 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Distribution Channel
  • 6.1. Retail Pharmacy
  • 6.1. Drug Stores
  • 6.2. Healthcare Institutions
  • 6.3. Clinics
  • 6.4. Research Institutes
• 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
  • 7.1. North America
  • 7.2. Latin America
  • 7.3. Western Europe
  • 7.4. Eastern Europe
  • 7.5. South Asia and Pacific
  • 7.6. East Asia
  • 7.7. Middle East and Africa
• 8. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 9. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 10. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 11. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 12. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 13. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 14. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 15. Key Countries Market Analysis
• 16. Market Structure Analysis
• 17. Competition Analysis
  • 17.1. Walmart Stores, Inc.
  • 17.2. Walgreen Co.
  • 17.3. CVS Health
  • 17.4. Express Scripts Holding Company
  • 17.5. Giant Eagle, Inc.
  • 17.6. DocMorris (Zur Rose Group AG)
  • 17.7. Rowlands Pharmacy
  • 17.8. OptumRx, Inc.
  • 17.9. Ali Health
  • 17.10. Kroger Co.
  • 17.11. Amazon (PillPack)
• 18. Assumptions & Acronyms Used
• 19. Research Methodology

List of Tables

Table 1: Global Market Value (US$ Million) Forecast by Region, 2019 to 2034

Table 2: Global Market Value (US$ Million) Forecast by Disease Indication, 2019 to 2034

Table 3: Global Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034

Table 4: North America Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 5: North America Market Value (US$ Million) Forecast by Disease Indication, 2019 to 2034

Table 6: North America Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034

Table 7: Latin America Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 8: Latin America Market Value (US$ Million) Forecast by Disease Indication, 2019 to 2034

Table 9: Latin America Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034

Table 10: Western Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 11: Western Europe Market Value (US$ Million) Forecast by Disease Indication, 2019 to 2034

Table 12: Western Europe Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034

Table 13: Eastern Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 14: Eastern Europe Market Value (US$ Million) Forecast by Disease Indication, 2019 to 2034

Table 15: Eastern Europe Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034

Table 16: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 17: South Asia and Pacific Market Value (US$ Million) Forecast by Disease Indication, 2019 to 2034

Table 18: South Asia and Pacific Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034

Table 19: East Asia Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 20: East Asia Market Value (US$ Million) Forecast by Disease Indication, 2019 to 2034

Table 21: East Asia Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034

Table 22: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 23: Middle East and Africa Market Value (US$ Million) Forecast by Disease Indication, 2019 to 2034

Table 24: Middle East and Africa Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034

List of Figures

Figure 1: Global Market Value (US$ Million) by Disease Indication, 2024 to 2034

Figure 2: Global Market Value (US$ Million) by Distribution Channel, 2024 to 2034

Figure 3: Global Market Value (US$ Million) by Region, 2024 to 2034

Figure 4: Global Market Value (US$ Million) Analysis by Region, 2019 to 2034

Figure 5: Global Market Value Share (%) and BPS Analysis by Region, 2024 to 2034

Figure 6: Global Market Y-o-Y Growth (%) Projections by Region, 2024 to 2034

Figure 7: Global Market Value (US$ Million) Analysis by Disease Indication, 2019 to 2034

Figure 8: Global Market Value Share (%) and BPS Analysis by Disease Indication, 2024 to 2034

Figure 9: Global Market Y-o-Y Growth (%) Projections by Disease Indication, 2024 to 2034

Figure 10: Global Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034

Figure 11: Global Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034

Figure 12: Global Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034

Figure 13: Global Market Attractiveness by Disease Indication, 2024 to 2034

Figure 14: Global Market Attractiveness by Distribution Channel, 2024 to 2034

Figure 15: Global Market Attractiveness by Region, 2024 to 2034

Figure 16: North America Market Value (US$ Million) by Disease Indication, 2024 to 2034

Figure 17: North America Market Value (US$ Million) by Distribution Channel, 2024 to 2034

Figure 18: North America Market Value (US$ Million) by Country, 2024 to 2034

Figure 19: North America Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 20: North America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 21: North America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 22: North America Market Value (US$ Million) Analysis by Disease Indication, 2019 to 2034

Figure 23: North America Market Value Share (%) and BPS Analysis by Disease Indication, 2024 to 2034

Figure 24: North America Market Y-o-Y Growth (%) Projections by Disease Indication, 2024 to 2034

Figure 25: North America Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034

Figure 26: North America Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034

Figure 27: North America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034

Figure 28: North America Market Attractiveness by Disease Indication, 2024 to 2034

Figure 29: North America Market Attractiveness by Distribution Channel, 2024 to 2034

Figure 30: North America Market Attractiveness by Country, 2024 to 2034

Figure 31: Latin America Market Value (US$ Million) by Disease Indication, 2024 to 2034

Figure 32: Latin America Market Value (US$ Million) by Distribution Channel, 2024 to 2034

Figure 33: Latin America Market Value (US$ Million) by Country, 2024 to 2034

Figure 34: Latin America Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 35: Latin America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 36: Latin America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 37: Latin America Market Value (US$ Million) Analysis by Disease Indication, 2019 to 2034

Figure 38: Latin America Market Value Share (%) and BPS Analysis by Disease Indication, 2024 to 2034

Figure 39: Latin America Market Y-o-Y Growth (%) Projections by Disease Indication, 2024 to 2034

Figure 40: Latin America Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034

Figure 41: Latin America Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034

Figure 42: Latin America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034

Figure 43: Latin America Market Attractiveness by Disease Indication, 2024 to 2034

Figure 44: Latin America Market Attractiveness by Distribution Channel, 2024 to 2034

Figure 45: Latin America Market Attractiveness by Country, 2024 to 2034

Figure 46: Western Europe Market Value (US$ Million) by Disease Indication, 2024 to 2034

Figure 47: Western Europe Market Value (US$ Million) by Distribution Channel, 2024 to 2034

Figure 48: Western Europe Market Value (US$ Million) by Country, 2024 to 2034

Figure 49: Western Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 50: Western Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 51: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 52: Western Europe Market Value (US$ Million) Analysis by Disease Indication, 2019 to 2034

Figure 53: Western Europe Market Value Share (%) and BPS Analysis by Disease Indication, 2024 to 2034

Figure 54: Western Europe Market Y-o-Y Growth (%) Projections by Disease Indication, 2024 to 2034

Figure 55: Western Europe Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034

Figure 56: Western Europe Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034

Figure 57: Western Europe Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034

Figure 58: Western Europe Market Attractiveness by Disease Indication, 2024 to 2034

Figure 59: Western Europe Market Attractiveness by Distribution Channel, 2024 to 2034

Figure 60: Western Europe Market Attractiveness by Country, 2024 to 2034

Figure 61: Eastern Europe Market Value (US$ Million) by Disease Indication, 2024 to 2034

Figure 62: Eastern Europe Market Value (US$ Million) by Distribution Channel, 2024 to 2034

Figure 63: Eastern Europe Market Value (US$ Million) by Country, 2024 to 2034

Figure 64: Eastern Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 65: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 66: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 67: Eastern Europe Market Value (US$ Million) Analysis by Disease Indication, 2019 to 2034

Figure 68: Eastern Europe Market Value Share (%) and BPS Analysis by Disease Indication, 2024 to 2034

Figure 69: Eastern Europe Market Y-o-Y Growth (%) Projections by Disease Indication, 2024 to 2034

Figure 70: Eastern Europe Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034

Figure 71: Eastern Europe Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034

Figure 72: Eastern Europe Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034

Figure 73: Eastern Europe Market Attractiveness by Disease Indication, 2024 to 2034

Figure 74: Eastern Europe Market Attractiveness by Distribution Channel, 2024 to 2034

Figure 75: Eastern Europe Market Attractiveness by Country, 2024 to 2034

Figure 76: South Asia and Pacific Market Value (US$ Million) by Disease Indication, 2024 to 2034

Figure 77: South Asia and Pacific Market Value (US$ Million) by Distribution Channel, 2024 to 2034

Figure 78: South Asia and Pacific Market Value (US$ Million) by Country, 2024 to 2034

Figure 79: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 80: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 81: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 82: South Asia and Pacific Market Value (US$ Million) Analysis by Disease Indication, 2019 to 2034

Figure 83: South Asia and Pacific Market Value Share (%) and BPS Analysis by Disease Indication, 2024 to 2034

Figure 84: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Disease Indication, 2024 to 2034

Figure 85: South Asia and Pacific Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034

Figure 86: South Asia and Pacific Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034

Figure 87: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034

Figure 88: South Asia and Pacific Market Attractiveness by Disease Indication, 2024 to 2034

Figure 89: South Asia and Pacific Market Attractiveness by Distribution Channel, 2024 to 2034

Figure 90: South Asia and Pacific Market Attractiveness by Country, 2024 to 2034

Figure 91: East Asia Market Value (US$ Million) by Disease Indication, 2024 to 2034

Figure 92: East Asia Market Value (US$ Million) by Distribution Channel, 2024 to 2034

Figure 93: East Asia Market Value (US$ Million) by Country, 2024 to 2034

Figure 94: East Asia Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 95: East Asia Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 96: East Asia Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 97: East Asia Market Value (US$ Million) Analysis by Disease Indication, 2019 to 2034

Figure 98: East Asia Market Value Share (%) and BPS Analysis by Disease Indication, 2024 to 2034

Figure 99: East Asia Market Y-o-Y Growth (%) Projections by Disease Indication, 2024 to 2034

Figure 100: East Asia Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034

Figure 101: East Asia Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034

Figure 102: East Asia Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034

Figure 103: East Asia Market Attractiveness by Disease Indication, 2024 to 2034

Figure 104: East Asia Market Attractiveness by Distribution Channel, 2024 to 2034

Figure 105: East Asia Market Attractiveness by Country, 2024 to 2034

Figure 106: Middle East and Africa Market Value (US$ Million) by Disease Indication, 2024 to 2034

Figure 107: Middle East and Africa Market Value (US$ Million) by Distribution Channel, 2024 to 2034

Figure 108: Middle East and Africa Market Value (US$ Million) by Country, 2024 to 2034

Figure 109: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 110: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 111: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 112: Middle East and Africa Market Value (US$ Million) Analysis by Disease Indication, 2019 to 2034

Figure 113: Middle East and Africa Market Value Share (%) and BPS Analysis by Disease Indication, 2024 to 2034

Figure 114: Middle East and Africa Market Y-o-Y Growth (%) Projections by Disease Indication, 2024 to 2034

Figure 115: Middle East and Africa Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034

Figure 116: Middle East and Africa Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034

Figure 117: Middle East and Africa Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034

Figure 118: Middle East and Africa Market Attractiveness by Disease Indication, 2024 to 2034

Figure 119: Middle East and Africa Market Attractiveness by Distribution Channel, 2024 to 2034

Figure 120: Middle East and Africa Market Attractiveness by Country, 2024 to 2034